Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus

Open access

Abstract

Chronic liver disease is rising in western countries and liver cirrhosis is the 12th leading cause of death worldwide. Simultaneously, use of gastric acid suppressive medications is increasing. Here, we show that proton pump inhibitors promote progression of alcoholic liver disease, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis in mice by increasing numbers of intestinal Enterococcus spp. Translocating enterococci lead to hepatic inflammation and hepatocyte death. Expansion of intestinal Enterococcus faecalis is sufficient to exacerbate ethanol-induced liver disease in mice. Proton pump inhibitor use increases the risk of developing alcoholic liver disease among alcohol-dependent patients. Reduction of gastric acid secretion therefore appears to promote overgrowth of intestinal Enterococcus, which promotes liver disease, based on data from mouse models and humans. Recent increases in the use of gastric acid-suppressive medications might contribute to the increasing incidence of chronic liver disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-017-00796-x

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Genetic deletion of gastric acid secretion exacerbates alcohol-induced liver disease in mice. a–h WT mice and their Atp4aSl/Sl littermates were fed an oral control diet (n = 3–8; 2–3 replicates) or ethanol diet (n = 6–16; 8–9 replicates) for 9 weeks following the chronic Lieber DeCarli diet model. a Plasma levels of ALT. b Representative liver sections after hematoxylin and eosin staining. c Hepatic triglyceride content. d Hepatic expression of cleaved IL1B protein (n = 2–5). e Hepatic areas of fibrosis were identified by staining with Sirius red (n = 2–6); area was quantitated by image analysis software. f Representative Sirius red-stained liver sections. g Total bacteria in feces (left panel). Fecal enterococci (mid panel). Principal component analysis of fecal microbiomes, performed using the ade4 R package46 (right panel). h Enterococcus in mesenteric lymph nodes (MLN) and liver, assessed by qPCR. i Proportions of positive Enterococcus cultures from liver tissues of WT mice (n = 6) and their Atp4aSl/Sl littermates (n = 11) subjected to chronic-plus-binge ethanol feeding. Results are expressed as mean ± s.e.m. Scale bars = 100 μm. For a, c, d, e, g, h significance was evaluated using the unpaired Student t-test or Mann–Whitney U-statistic test. For i, significance was evaluated using Fisher’s exact test.*P < 0.05
Fig. 1 Genetic deletion of gastric acid secretion exacerbates alcohol-induced liver disease in mice. a–h WT mice and their Atp4aSl/Sl littermates were fed an oral control diet (n = 3–8; 2–3 replicates) or ethanol diet (n = 6–16; 8–9 replicates) for 9 weeks following the chronic Lieber DeCarli diet model. a Plasma levels of ALT. b Representative liver sections after hematoxylin and eosin staining. c Hepatic triglyceride content. d Hepatic expression of cleaved IL1B protein (n = 2–5). e Hepatic areas of fibrosis were identified by staining with Sirius red (n = 2–6); area was quantitated by image analysis software. f Representative Sirius red-stained liver sections. g Total bacteria in feces (left panel). Fecal enterococci (mid panel). Principal component analysis of fecal microbiomes, performed using the ade4 R package46 (right panel). h Enterococcus in mesenteric lymph nodes (MLN) and liver, assessed by qPCR. i Proportions of positive Enterococcus cultures from liver tissues of WT mice (n = 6) and their Atp4aSl/Sl littermates (n = 11) subjected to chronic-plus-binge ethanol feeding. Results are expressed as mean ± s.e.m. Scale bars = 100 μm. For a, c, d, e, g, h significance was evaluated using the unpaired Student t-test or Mann–Whitney U-statistic test. For i, significance was evaluated using Fisher’s exact test.*P < 0.05CC BY · PubMed Central
Fig. 2 NAFLD is increased in Atp4aSl/Sl mice. WT mice and their Atp4aSl/Sl littermates were fed a regular chow (RC) diet (n = 5–8; 2–3 replicates) or a HFD (n = 6–15; 3–6 replicates) for 9 weeks. a Body weight and weight of white epididymal fat. b Hepatic triglyceride content and hepatic steatosis visualized with Oil Red O staining and quantified by image analysis software (n = 5–10). Scale bar = 100 μm. c Representative Oil Red O-stained liver sections. d Insulin tolerance test (ITT) (n = 5–10). e–f Representative liver sections of F4/80 immunofluorescence staining; the positively stained area was quantified by image analysis software (n = 3–6). Scale bar = 50 μm. g Hepatic levels of cleaved IL1B (n = 2–5). h Hepatic expression of mRNA encoding Col1a1. i Total bacteria, Enterococcus, E. coli, and Prevotella in fecal samples, measured by qPCR. Changes in fecal numbers of E. coli and Prevotella did not differ significantly between Atp4aSl/Sl mice fed a HFD vs. WT mice fed a HFD (n = 5–10). Atp4aSl/Sl mice fed a HFD had significantly higher numbers in Enterococcus than WT mice fed a HFD. Results are expressed as mean ± s.e.m. For a, b, d, e, g, h, i significance was evaluated using the unpaired Student t-test or Mann–Whitney U-statistic test. *P < 0.05
Fig. 2 NAFLD is increased in Atp4aSl/Sl mice. WT mice and their Atp4aSl/Sl littermates were fed a regular chow (RC) diet (n = 5–8; 2–3 replicates) or a HFD (n = 6–15; 3–6 replicates) for 9 weeks. a Body weight and weight of white epididymal fat. b Hepatic triglyceride content and hepatic steatosis visualized with Oil Red O staining and quantified by image analysis software (n = 5–10). Scale bar = 100 μm. c Representative Oil Red O-stained liver sections. d Insulin tolerance test (ITT) (n = 5–10). e–f Representative liver sections of F4/80 immunofluorescence staining; the positively stained area was quantified by image analysis software (n = 3–6). Scale bar = 50 μm. g Hepatic levels of cleaved IL1B (n = 2–5). h Hepatic expression of mRNA encoding Col1a1. i Total bacteria, Enterococcus, E. coli, and Prevotella in fecal samples, measured by qPCR. Changes in fecal numbers of E. coli and Prevotella did not differ significantly between Atp4aSl/Sl mice fed a HFD vs. WT mice fed a HFD (n = 5–10). Atp4aSl/Sl mice fed a HFD had significantly higher numbers in Enterococcus than WT mice fed a HFD. Results are expressed as mean ± s.e.m. For a, b, d, e, g, h, i significance was evaluated using the unpaired Student t-test or Mann–Whitney U-statistic test. *P < 0.05CC BY · PubMed Central
Fig. 3 Exacerbated NASH in Atp4aSl/Sl mice. WT mice and their Atp4aSl/Sl littermates were fed a CSAA (control, n = 4–9; 1–3 replicates) or CDAA diet (n = 10–12; 4–5 replicates) for 20 weeks. a Ratio of liver to body weight was significantly higher in CDAA-fed Atp4aSl/Sl mice than CDAA-fed WT mice, b as was mean plasma level of ALT. c Representative liver sections, stained with hematoxylin and eosin. d Hepatic triglyceride content. The Oil Red O-stained area was quantified by image analysis (n = 5–12). e Representative Oil Red O-stained liver sections. f Hepatic expression of mRNA encoding the chemokine Cxcl1. g Hepatic levels of cleaved IL1B (n = 2–5). h Collagen deposition was evaluated by Sirius red staining and quantified by image analysis (n = 5–13). i Representative sections stained with Sirius red. j Hepatic expression of genes involved in liver fibrosis including Col1a1, Acta2 (smooth muscle α-actin, a marker of activated myofibroblasts), and Timp1 (tissue inhibitor of metalloproteinase 1). k Total bacteria, proportions of Enterococcus, E. coli, and Prevotella in fecal samples, measured by qPCR. Proportions of fecal E. coli did not differ significantly between WT and Atp4aSl/Sl mice. Numbers of Prevotella were lower in Atp4aSl/Sl mice than in WT mice, with or without CDAA feeding. Numbers of Enterococcus were significantly higher in Atp4aSl/Sl mice than in WT mice, with or without CDAA feeding. Scale bars = 100 μm. Results are expressed as mean ± s.e.m. For a, b, d, f, g, h, j, k significance was evaluated using the unpaired Student t-test or Mann–Whitney U-statistic test.*P < 0.05
Fig. 3 Exacerbated NASH in Atp4aSl/Sl mice. WT mice and their Atp4aSl/Sl littermates were fed a CSAA (control, n = 4–9; 1–3 replicates) or CDAA diet (n = 10–12; 4–5 replicates) for 20 weeks. a Ratio of liver to body weight was significantly higher in CDAA-fed Atp4aSl/Sl mice than CDAA-fed WT mice, b as was mean plasma level of ALT. c Representative liver sections, stained with hematoxylin and eosin. d Hepatic triglyceride content. The Oil Red O-stained area was quantified by image analysis (n = 5–12). e Representative Oil Red O-stained liver sections. f Hepatic expression of mRNA encoding the chemokine Cxcl1. g Hepatic levels of cleaved IL1B (n = 2–5). h Collagen deposition was evaluated by Sirius red staining and quantified by image analysis (n = 5–13). i Representative sections stained with Sirius red. j Hepatic expression of genes involved in liver fibrosis including Col1a1, Acta2 (smooth muscle α-actin, a marker of activated myofibroblasts), and Timp1 (tissue inhibitor of metalloproteinase 1). k Total bacteria, proportions of Enterococcus, E. coli, and Prevotella in fecal samples, measured by qPCR. Proportions of fecal E. coli did not differ significantly between WT and Atp4aSl/Sl mice. Numbers of Prevotella were lower in Atp4aSl/Sl mice than in WT mice, with or without CDAA feeding. Numbers of Enterococcus were significantly higher in Atp4aSl/Sl mice than in WT mice, with or without CDAA feeding. Scale bars = 100 μm. Results are expressed as mean ± s.e.m. For a, b, d, f, g, h, j, k significance was evaluated using the unpaired Student t-test or Mann–Whitney U-statistic test.*P < 0.05CC BY · PubMed Central
Fig. 4 Pharmacological gastric acid suppression promotes progression of alcohol-induced liver disease in mice. C57BL/6 mice were fed an oral control diet (n = 4–6; 1–2 replicates) or ethanol diet (n = 11–18; 1–2 replicates) that contained PPI (200 p.p.m.) or vehicle (water) for 9 weeks. a Plasma levels of ALT. b Representative liver sections after hematoxylin and eosin staining. c Hepatic triglyceride content. d Hepatic levels of cleaved IL1B protein (n = 2–5). e Hepatic areas of fibrosis were identified by staining with Sirius red (n = 2–7); area was quantitated by image analysis software. f Representative Sirius red-stained liver sections. g Total bacteria and total amount of enterococci in feces. h Enterococcus in mesenteric lymph nodes (MLN) and liver, assessed by qPCR. Scale bars = 100 μm. Results are expressed as mean ± s.e.m. For a, c–e, g, h significance was evaluated using the unpaired Student t-test or Mann–Whitney U-statistic test. *P < 0.05
Fig. 4 Pharmacological gastric acid suppression promotes progression of alcohol-induced liver disease in mice. C57BL/6 mice were fed an oral control diet (n = 4–6; 1–2 replicates) or ethanol diet (n = 11–18; 1–2 replicates) that contained PPI (200 p.p.m.) or vehicle (water) for 9 weeks. a Plasma levels of ALT. b Representative liver sections after hematoxylin and eosin staining. c Hepatic triglyceride content. d Hepatic levels of cleaved IL1B protein (n = 2–5). e Hepatic areas of fibrosis were identified by staining with Sirius red (n = 2–7); area was quantitated by image analysis software. f Representative Sirius red-stained liver sections. g Total bacteria and total amount of enterococci in feces. h Enterococcus in mesenteric lymph nodes (MLN) and liver, assessed by qPCR. Scale bars = 100 μm. Results are expressed as mean ± s.e.m. For a, c–e, g, h significance was evaluated using the unpaired Student t-test or Mann–Whitney U-statistic test. *P < 0.05CC BY · PubMed Central
Fig. 5 Changes of intestinal Enterococcus growth in the absence of gastric acid during chronic ethanol feeding. a WT mice and their Atp4aSl/Sl littermates were fed an ethanol diet (n = 3–5) for 2 weeks. We used an in vivo assay to measure luminal killing of E. coli and E. faecalis in the gut17, 38, 42. A 4 cm loop of the proximal jejunum was ligated (without interrupting the blood supply) in anesthetized mice and injected with bioluminescent E. coli or E. faecalis. To analyze luminal survival and killing, we performed IVIS imaging of bioluminescent E. coli and E. faecalis at 80 and 90 min, respectively, after injection of bacteria into ligated jejunal loops. Representative images are shown. Whereas loops of ethanol-fed Atp4aSl/Sl mice had a similar amount of bioluminescent E. coli than ethanol-fed WT mice, bioluminescent E. faecalis was found to be ninefold higher in Atp4aSl/Sl than WT mice. b The graph shows survival in percentage of injected E. coli and E. faecalis. c C57BL/6 mice were fed an ethanol diet with or without a PPI (200 p.p.m.) for 9 weeks, before the PPI was discontinued. Fecal Enterococcus and total luminal bacteria were measured by qPCR (n = 2–12) (2 replicates). Results are expressed as mean ± s.e.m. For b, c significance was evaluated using the unpaired Student t-test or Mann–Whitney U-statistic test. *P < 0.05
Fig. 5 Changes of intestinal Enterococcus growth in the absence of gastric acid during chronic ethanol feeding. a WT mice and their Atp4aSl/Sl littermates were fed an ethanol diet (n = 3–5) for 2 weeks. We used an in vivo assay to measure luminal killing of E. coli and E. faecalis in the gut17, 38, 42. A 4 cm loop of the proximal jejunum was ligated (without interrupting the blood supply) in anesthetized mice and injected with bioluminescent E. coli or E. faecalis. To analyze luminal survival and killing, we performed IVIS imaging of bioluminescent E. coli and E. faecalis at 80 and 90 min, respectively, after injection of bacteria into ligated jejunal loops. Representative images are shown. Whereas loops of ethanol-fed Atp4aSl/Sl mice had a similar amount of bioluminescent E. coli than ethanol-fed WT mice, bioluminescent E. faecalis was found to be ninefold higher in Atp4aSl/Sl than WT mice. b The graph shows survival in percentage of injected E. coli and E. faecalis. c C57BL/6 mice were fed an ethanol diet with or without a PPI (200 p.p.m.) for 9 weeks, before the PPI was discontinued. Fecal Enterococcus and total luminal bacteria were measured by qPCR (n = 2–12) (2 replicates). Results are expressed as mean ± s.e.m. For b, c significance was evaluated using the unpaired Student t-test or Mann–Whitney U-statistic test. *P < 0.05CC BY · PubMed Central
Fig. 6 Numbers of Enterococcus in human fecal samples and effects of E. faecalis on progression of alcohol-induced liver disease in mice. a Fecal amounts of Enterococcus in healthy individuals before (n = 13) and after taking a PPI (omeprazole, 40 mg) daily for 14 days (n = 12). b–i C57BL/6 mice were gavaged with polymyxin B 150 mg kg−1 and neomycin 200 mg kg−1 body weight once daily for 1 week to facilitate colonization of E. faecalis. Mice were then fed an oral control diet (n = 3–9; 1–2 replicates) or ethanol diet (n = 13–25; 1–2 replicates) for 9 weeks and gavaged with E. faecalis (5 × 109 CFUs) or vehicle (water) every third day. b Enterococci (left panel) and total amount of bacteria (right panel) in feces. Samples used to measure enterococci in ethanol-fed Atp4aSl/Sl mice and in C57BL/6 mice fed ethanol or given PPIs are the same as in Figs. 1g and 2g, respectively. c Plasma levels of ALT. d Representative liver sections after hematoxylin and eosin staining. e Hepatic triglyceride content. f Hepatic expression of cleaved IL1B protein (n = 2–5). g Hepatic areas of fibrosis were identified by staining with Sirius red (n = 3–10); area was quantitated by image analysis software. h Representative Sirius red-stained liver sections. i Enterococcus in liver, assessed by qPCR. Scale bars = 100 μm. Results are expressed as mean ± s.e.m. For a–c, e–g, i significance was evaluated using the unpaired Student t-test or Mann–Whitney U-statistic test. *P < 0.05
Fig. 6 Numbers of Enterococcus in human fecal samples and effects of E. faecalis on progression of alcohol-induced liver disease in mice. a Fecal amounts of Enterococcus in healthy individuals before (n = 13) and after taking a PPI (omeprazole, 40 mg) daily for 14 days (n = 12). b–i C57BL/6 mice were gavaged with polymyxin B 150 mg kg−1 and neomycin 200 mg kg−1 body weight once daily for 1 week to facilitate colonization of E. faecalis. Mice were then fed an oral control diet (n = 3–9; 1–2 replicates) or ethanol diet (n = 13–25; 1–2 replicates) for 9 weeks and gavaged with E. faecalis (5 × 109 CFUs) or vehicle (water) every third day. b Enterococci (left panel) and total amount of bacteria (right panel) in feces. Samples used to measure enterococci in ethanol-fed Atp4aSl/Sl mice and in C57BL/6 mice fed ethanol or given PPIs are the same as in Figs. 1g and 2g, respectively. c Plasma levels of ALT. d Representative liver sections after hematoxylin and eosin staining. e Hepatic triglyceride content. f Hepatic expression of cleaved IL1B protein (n = 2–5). g Hepatic areas of fibrosis were identified by staining with Sirius red (n = 3–10); area was quantitated by image analysis software. h Representative Sirius red-stained liver sections. i Enterococcus in liver, assessed by qPCR. Scale bars = 100 μm. Results are expressed as mean ± s.e.m. For a–c, e–g, i significance was evaluated using the unpaired Student t-test or Mann–Whitney U-statistic test. *P < 0.05CC BY · PubMed Central
Fig. 7 MYD88/TRIF, TLR2 or IL1-receptor inhibition protects from E. faecalis -exacerbated alcoholic liver disease. C57BL/6 mice were irradiated, given transplants of WT, Myd88−/−/TrifLPS2/LPS2 (Myd88/TrifΔBM), or Tlr2−/− bone marrow (Tlr2ΔBM) and injected with clodronate liposomes. Mice were then gavaged with polymyxin B 150 mg kg−1 and neomycin 200 mg kg−1 body weight once daily for 1 week to facilitate colonization of E. faecalis, fed the ethanol diet for 9 weeks, and gavaged with E. faecalis (5 × 109 CFUs; n = 14–27; 1–3 replicates) or vehicle (water; n = 14–29) (1–3 replicates) every third day. A subset of WT mice given transplants of WT bone marrow received the IL1-receptor antagonist anakinra. a Ratio of liver to body weight. b Plasma levels of ALT. c Representative liver sections after hematoxylin and eosin staining. d Hepatic triglyceride content. e Hepatic levels of cleaved IL1B (n = 3). f Hepatic areas of fibrosis were identified by staining with Sirius red; area was quantified by image analysis software (n = 6–17). g Representative Sirius red-stained liver sections. Scale bar = 100 μm. Results are expressed as mean ± s.e.m. For a, b, d–f significance was evaluated using one-way analysis of variance with Newman–Keuls post-test. *P < 0.05
Fig. 7 MYD88/TRIF, TLR2 or IL1-receptor inhibition protects from E. faecalis -exacerbated alcoholic liver disease. C57BL/6 mice were irradiated, given transplants of WT, Myd88−/−/TrifLPS2/LPS2 (Myd88/TrifΔBM), or Tlr2−/− bone marrow (Tlr2ΔBM) and injected with clodronate liposomes. Mice were then gavaged with polymyxin B 150 mg kg−1 and neomycin 200 mg kg−1 body weight once daily for 1 week to facilitate colonization of E. faecalis, fed the ethanol diet for 9 weeks, and gavaged with E. faecalis (5 × 109 CFUs; n = 14–27; 1–3 replicates) or vehicle (water; n = 14–29) (1–3 replicates) every third day. A subset of WT mice given transplants of WT bone marrow received the IL1-receptor antagonist anakinra. a Ratio of liver to body weight. b Plasma levels of ALT. c Representative liver sections after hematoxylin and eosin staining. d Hepatic triglyceride content. e Hepatic levels of cleaved IL1B (n = 3). f Hepatic areas of fibrosis were identified by staining with Sirius red; area was quantified by image analysis software (n = 6–17). g Representative Sirius red-stained liver sections. Scale bar = 100 μm. Results are expressed as mean ± s.e.m. For a, b, d–f significance was evaluated using one-way analysis of variance with Newman–Keuls post-test. *P < 0.05CC BY · PubMed Central
Fig. 8 E. faecalis causes an inflammatory and hepatotoxic response mediated by TLR2 on Kupffer cells. a C57BL/6 mice were irradiated, given transplants of WT or Myd88−/−/TrifLPS2/LPS2 bone marrow (Myd88/TrifΔBM), and injected with clodronate liposomes. Mice were then gavaged with polymyxin B 150 mg kg−1 and neomycin 200 mg kg−1 body weight once daily for 1 week to facilitate colonization of E. faecalis, fed the ethanol diet for 9 weeks and gavaged with E. faecalis (5 × 109 CFUs) every third day. Immunofluorescence analysis of F4/80 (red) and IL1B (green; representative liver sections); nuclei are blue. Scale bar = 10 μm. b Primary mouse WT and Tlr2−/− Kupffer cells were stimulated with heat-inactivated, sonicated E. faecalis for 8 h; expression of genes encoding inflammatory mediators was measured (n = 4–5 independent experiments). Results are expressed relative to the level of unstimulated WT Kupffer cells within each experiment. c, d Conditioned medium (CM) from Kupffer cells (KC; stimulated or not stimulated with heat-inactivated, sonicated E. faecalis) was transferred to ethanol-stimulated (100 mM) primary mouse hepatocytes in the presence of a control (IgG) or IL1B neutralizing antibody. c Hepatocyte cytotoxicity (n = 3 independent experiments performed in 2–6 replicates) and total IL1B in the cell supernatant (2–6 replicates) (d). Results are expressed as mean ± s.e.m.. For b–d significance was evaluated using the unpaired Student t-test or Mann–Whitney U-statistic test. *P < 0.05
Fig. 8 E. faecalis causes an inflammatory and hepatotoxic response mediated by TLR2 on Kupffer cells. a C57BL/6 mice were irradiated, given transplants of WT or Myd88−/−/TrifLPS2/LPS2 bone marrow (Myd88/TrifΔBM), and injected with clodronate liposomes. Mice were then gavaged with polymyxin B 150 mg kg−1 and neomycin 200 mg kg−1 body weight once daily for 1 week to facilitate colonization of E. faecalis, fed the ethanol diet for 9 weeks and gavaged with E. faecalis (5 × 109 CFUs) every third day. Immunofluorescence analysis of F4/80 (red) and IL1B (green; representative liver sections); nuclei are blue. Scale bar = 10 μm. b Primary mouse WT and Tlr2−/− Kupffer cells were stimulated with heat-inactivated, sonicated E. faecalis for 8 h; expression of genes encoding inflammatory mediators was measured (n = 4–5 independent experiments). Results are expressed relative to the level of unstimulated WT Kupffer cells within each experiment. c, d Conditioned medium (CM) from Kupffer cells (KC; stimulated or not stimulated with heat-inactivated, sonicated E. faecalis) was transferred to ethanol-stimulated (100 mM) primary mouse hepatocytes in the presence of a control (IgG) or IL1B neutralizing antibody. c Hepatocyte cytotoxicity (n = 3 independent experiments performed in 2–6 replicates) and total IL1B in the cell supernatant (2–6 replicates) (d). Results are expressed as mean ± s.e.m.. For b–d significance was evaluated using the unpaired Student t-test or Mann–Whitney U-statistic test. *P < 0.05CC BY · PubMed Central
Fig. 9 PPI treatment increases the risk of liver disease in chronic alcoholics. a Cumulative risk of ALD based on use of PPIs. A Cox regression model was used to compare risk among active, previous, and never users. b Fecal amounts of Enterococcus in chronic consumers of alcohol taking PPIs (n = 3) and not taking PPI (n = 8). Results are expressed as mean ± s.e.m. For a, a Cox regression model was used to compare risk among PPI users in a cohort of alcohol-dependent patients.For b, significance was evaluated using Student t-test. *P < 0.05
Fig. 9 PPI treatment increases the risk of liver disease in chronic alcoholics. a Cumulative risk of ALD based on use of PPIs. A Cox regression model was used to compare risk among active, previous, and never users. b Fecal amounts of Enterococcus in chronic consumers of alcohol taking PPIs (n = 3) and not taking PPI (n = 8). Results are expressed as mean ± s.e.m. For a, a Cox regression model was used to compare risk among PPI users in a cohort of alcohol-dependent patients.For b, significance was evaluated using Student t-test. *P < 0.05CC BY · PubMed Central
Fig. 10 Gastric acid suppression and alcoholic liver disease. Gastric acid suppression increases intestinal Enterococcus, which translocates to the liver via the portal vein. Enterococcus binds to the pathogen recognition receptor TLR2 on hepatic Kupffer cells, leading to secretion of IL1B. IL1B contributes to ethanol-induced liver inflammation and hepatocyte damage
Fig. 10 Gastric acid suppression and alcoholic liver disease. Gastric acid suppression increases intestinal Enterococcus, which translocates to the liver via the portal vein. Enterococcus binds to the pathogen recognition receptor TLR2 on hepatic Kupffer cells, leading to secretion of IL1B. IL1B contributes to ethanol-induced liver inflammation and hepatocyte damageCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Cited by

See all 257

Metadata

Authors
Llorente, C., Jepsen, P., Inamine, T., Wang, L., Bluemel, S., Wang, H. J., Loomba, R., Bajaj, J. S., Schubert, M. L., Sikaroodi, M., Gillevet, P. M., Xu, J., Kisseleva, T., Ho, S. B., DePew, J., Du, X., Sørensen, H. T., Vilstrup, H., Nelson, K. E., Brenner, D. A., Fouts, D. E., & Schnabl, B.
Affiliations
  • University of California San Diego (US)
  • Aarhus University Hospital (DK)
  • Virginia Commonwealth University (US)
  • George Mason University (US)
  • J. Craig Venter Institute (US)
Corresponding author
Schnabl, Bernd
Venue
Nature Communications
Published
2017-10-16
Volume
8
Issue
1
Pages
837-837
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2761437180
Cited by
257
References
46
Citations by year
2026: 13 · 2025: 21 · 2024: 32 · 2023: 25 · 2022: 24 · 2021: 32 · 2020: 53 · 2019: 29 · 2018: 23 · 2017: 4
FWCI
12.18
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • Scopus (Elsevier) (submittedVersion, other-oa)
Funders
  • U.S. Department of Veterans Affairs (I01BX002213)
  • Office of Research and Development (CX10076)
  • National Institutes of Health (I01BX002213, R01DK089713, R01‐AA020703, AA020703)
  • National Institute on Alcohol Abuse and Alcoholism (R01AA020703, U01AA024726, U01AA021856)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
proton pump inhibitors, gastric acid suppression, alcoholic liver disease, Enterococcus faecalis, intestinal bacterial overgrowth, nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, gut microbiota, ethanol-induced liver injury, hepatocyte death, liver inflammation, alcoholism, chronic liver disease
MeSH terms
Animals, Female, Gastric Acid, Humans, Liver Diseases, Alcoholic, Male, Mice, Inbred C57BL, Incidence, Enterococcus, Disease Progression, Mice, Proton Pump Inhibitors, Microbiota, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus. https://app.cochat.ai/papers/10.1038/s41467-017-00796-x
The paper
Llorente, C., Jepsen, P., Inamine, T., Wang, L., Bluemel, S., Wang, H. J., Loomba, R., Bajaj, J. S., Schubert, M. L., Sikaroodi, M., Gillevet, P. M., Xu, J., Kisseleva, T., Ho, S. B., DePew, J., Du, X., Sørensen, H. T., Vilstrup, H., Nelson, K. E., . . . Schnabl, B. (2017). Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus. Nature Communications. https://doi.org/10.1038/s41467-017-00796-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.